Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.
Generare has raised $23.1M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Generare's investors include Daphni, Alven, Teampact ventures, Galion.exe, Better Angle.
Generare is headquartered in Paris, France.
Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria.
Generare is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Generare — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/generare. Accessed September 8, 2026.
VCBacked. (2026). Generare — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/generare
{{cite web |title=Generare — Funding & Investors |url=https://www.vcbacked.co/company/generare |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated